arrow
C

Claire Falandry

inserm and université lyon 1 and inrae and hospices civils lyon
H指数:33
被引数:5,329

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Guidelines to optimise ePROs monitoring for older patients under systemic cancer treatment from the French Society of Geriatric oncology (SoFOG) based on a delphi consensus

法国老年肿瘤学会(SoFOG)基于德尔菲共识提出的优化系统性癌症治疗下老年患者电子患者报告结局(ePROs)监测的指南

2025-10-040
OAAI
Safety and quality of life with maintenance olaparib plus bevacizumab in older patients with ovarian cancer: subgroup analysis of PAOLA-1/ENGOT-ov25
2024-12-011
PRE
Tolerance of adjuvant chemotherapy in older patients after resection of stage III colon adenocarcinoma from PRODIGE 34-FFCD 1402-ADAGE randomized phase III trial

PRODIGE 34-FFCD 1402-ADAGE 随机III期试验中,III期结肠腺癌切除术后老年患者辅助化疗的耐受性

2024-09-010
PRE
Adapted EXTREME regimen in the first-line treatment of fit older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, singlearm, phase 2 trial
2024-06-012
OA
Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3trial
2024-03-010
OA
ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease

ESGO-ESMO-ESP共识会议关于卵巢癌的建议: 病理学和分子生物学以及早期,晚期和复发性疾病

2024-03-0146
OA
Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon cancer from the PRODIGE 34-FFCD randomized trial
2023-04-019
OAAI